Lipid lowering in high-risk populations: how low should we go?
Watson
K
K
UCLA School of Medicine, Division of Cardiology, Los Angeles, California 90095, USA. kwatson@mednet.ucla.edu
D001741:Black or African American; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D017408:Guidelines as Topic; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D015994:Incidence; D007333:Insulin Resistance; D008049:Lipase / Q000097:blood; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D008049:Lipase